Combination Treatment of C16 Peptide and Angiopoietin-1 Alleviates Neuromyelitis Optica in an Experimental Model
Neuromyelitis optica (NMO) is an autoimmune inflammatory demyelinating disease that mainly affects the spinal cord and optic nerve, causing blindness and paralysis in some individuals. Moreover, NMO may cause secondary complement-dependent cytotoxicity (CDC), leading to oligodendrocyte and neuronal...
Saved in:
Main Authors: | Yuanyuan Zhang (Author), Kewei Tian (Author), Hong Jiang (Author), Beibei Wang (Author), Shu Han (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
C16 Peptide Promotes Vascular Growth and Reduces Inflammation in a Neuromyelitis Optica Model
by: Haohao Chen, et al.
Published: (2019) -
Circulating Memory T Follicular Helper Cells in Patients with Neuromyelitis Optica/Neuromyelitis Optica Spectrum Disorders
by: Xueli Fan, et al.
Published: (2016) -
Prognosis of Relapsing Neuromyelitis Optica
by: J Gordon Millichap
Published: (2003) -
Pediatric neuromyelitis optica spectrum disorder
by: Aman Mehta
Published: (2024) -
Myasthenia Gravis and Neuromyelitis Optica Association
by: J Gordon Millichap
Published: (2012)